Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02150044 · ClinicalTrials.gov registry record · NA
Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02150044 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 29 participants.
The verdict
NCT02150044, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This was a non-significant risk (NSR), prospective, multi-center, single arm clinical trial that aimed to evaluate safety and performance of the Acclarent Tympanostomy Tube Delivery System (TTDS).
Interventions
- DEVICE Acclarent Tympanostomy Tube Delivery System (TTDS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02150044
The ClinicalTrials.gov registry entry for NCT02150044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acclarent Tympanostomy Tube Delivery System (TTDS). is the first listed.
NCT02150044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02150044 about?
NCT02150044 is a clinical study titled "Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion". This was a non-significant risk (NSR), prospective, multi-center, single arm clinical trial that aimed to evaluate safety and performance of the Acclarent Tympanostomy Tube Delivery System (TTDS).
What is the current status of trial NCT02150044?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2010-02. Estimated completion is 2010-11.
What interventions are being tested in trial NCT02150044?
The interventions under investigation include: Acclarent Tympanostomy Tube Delivery System (TTDS). (DEVICE).
Who is sponsoring clinical trial NCT02150044?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.